Plexxikon

Plexxikon

Plexxikon

Plexxikon has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including oncology, CNS and autoimmune & bone..
Founded
2000
Raised
$46M
Follow us
Alexa global traffic share
Acquired by
Daiichi Sankyo Co., Ltd.
28 Feb 2011
$935,000,000
Latest funding
$46,000,000
Venture capital (Series B) - 2004

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Plexxikon makes some noise.